Professor | Na Xie | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Na Xie
Contact Information	xnshina@126.com
Language ability	Chinese, English
Province	Sichuan

Upload Avatar (500 x 500)

Name

Na Xie

Contact Information

xnshina@126.com

Language ability

Chinese, English

Province

Sichuan

University/Lab Affiliation and Title	Sichuan University
Faculty	West China Institute of Basic Medicine and Forensic Medicine
Academic Background & Achievements	2014 - PhD: Sichuan University, State Key Laboratory of Biotherapy Achievement: Published over 20 academic papers as first or corresponding author, with 4 papers selected as ESI highly cited papers
Work Experience	2015-2019 - University of Southern California - Visiting Scholar Postdoctoral Research - Sichuan University, West China Hospital
Awards	First Prize of the Ministry of Education Natural Science Award: Ninth Contributor Selected as a reserve candidate for the 14th batch of academic and technical leaders in Sichuan Province

University/Lab Affiliation and Title

Sichuan University

Faculty

West China Institute of Basic Medicine and Forensic Medicine

Academic Background & Achievements

2014 - PhD: Sichuan University, State Key Laboratory of Biotherapy
Achievement: Published over 20 academic papers as first or corresponding author, with 4 papers selected as ESI highly cited papers

Work Experience

2015-2019 - University of Southern California - Visiting Scholar
Postdoctoral Research - Sichuan University, West China Hospital

Awards

First Prize of the Ministry of Education Natural Science Award: Ninth Contributor
Selected as a reserve candidate for the 14th batch of academic and technical leaders in Sichuan Province

Areas of Focus	Interaction networks in virus-induced tumorigenesis Oxidative stress Metabolic regulation Cell autophagy mechanisms and intervention strategies
Publications	Neoantigens: promising targets for cancer therapy, Xie N, Shen G, Gao W, Huang Z, Huang C#, Fu L#, 2023 Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer, Li L, Tian H, Zhang Z, Ding N, He K, Lu S, Liu R, Wu P, Wang Y, He B, Luo M, Peng P, Yang M, Nice EC, Huang C, Xie N#, Wang D#, Gao W#, 2023 Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer, Chen X, Feng L, Huang Y, Wu Y, Xie N#, 2023 Nanoengineering a Zeolitic Imidazolate Framework-8 Capable of Manipulating Energy Metabolism against Cancer Chemo-Phototherapy Resistance, Lu S, Tian H, Li L, Li B, Yang M, Zhou L, Jiang H, Li Q, Wang W, Nice EC, Xie N#, Huang C#, Liu L#, 2022 Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling, Duan J, Huang Z, Nice EC, Xie N#, Chen M#, Huang C#, 2022 Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies, Tian H, Zhang T, Qin S, Huang Z, Zhou L, Shi J, Nice EC, Xie N#, Huang C#, Shen Z#, 2022 Exosomes as Anticancer Drug Delivery Vehicles: Prospects and Challenges, Zhang Y, Li J, Gao W#, Xie N#, 2022 Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications, Wu P, Han J, Gong Y, Liu C, Yu H#, Xie N#, 2022 Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinoma, An Y, Jiang J, Zhou L, Shi J, Jin P, Li L, Peng L, He S, Zhang W, Huang C, Zou B#, Xie N#, 2021 From purines to purinergic signalling: molecular functions and human diseases, Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu SG, Huang C, Tang Y, 2021 Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment, Wu P, Gao W, Su M, Nice EC, Zhang W, Lin J#, Xie N#, 2021 NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential, Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, Li C#, Shen G#, Zou B#, 2020 Managing therapeutic resistance in breast cancer: from the lncRNAs perspective, Peng L, Jiang J, Tang B, Nice EC, Zhang YY#, Xie N#, 2020 Overcoming cancer therapeutic bottleneck by drug repurposing, Zhang Z, Zhou L, Xie N, Nice EC, Zhang T, Cui Y, Huang C, 2020 PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation, Xie N, Yuan K, Zhou L, Wang K, Chen HN, Lei Y, Lan J, Pu Q, Gao W, Zhang L, Shen G, Li Q, Xiao H, Tang H, Xiang R, He M, Feng P, Nice EC, Wei Y, Zhang H, Yang J, Huang C, 2016

Areas of Focus

Interaction networks in virus-induced tumorigenesis
Oxidative stress
Metabolic regulation
Cell autophagy mechanisms and intervention strategies

Publications

Neoantigens: promising targets for cancer therapy, Xie N*, Shen G*, Gao W, Huang Z, Huang C#, Fu L#, 2023
Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer, Li L, Tian H, Zhang Z, Ding N, He K, Lu S, Liu R, Wu P, Wang Y, He B, Luo M, Peng P, Yang M, Nice EC, Huang C, Xie N#, Wang D#, Gao W#, 2023
Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer, Chen X, Feng L, Huang Y, Wu Y, Xie N#, 2023
Nanoengineering a Zeolitic Imidazolate Framework-8 Capable of Manipulating Energy Metabolism against Cancer Chemo-Phototherapy Resistance, Lu S, Tian H, Li L, Li B, Yang M, Zhou L, Jiang H, Li Q, Wang W, Nice EC, Xie N#, Huang C#, Liu L#, 2022
Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling, Duan J, Huang Z, Nice EC, Xie N#, Chen M#, Huang C#, 2022
Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies, Tian H, Zhang T, Qin S, Huang Z, Zhou L, Shi J, Nice EC, Xie N#, Huang C#, Shen Z#, 2022
Exosomes as Anticancer Drug Delivery Vehicles: Prospects and Challenges, Zhang Y, Li J, Gao W#, Xie N#, 2022
Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications, Wu P, Han J, Gong Y, Liu C, Yu H#, Xie N#, 2022
Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinoma, An Y, Jiang J, Zhou L, Shi J, Jin P, Li L, Peng L, He S, Zhang W, Huang C, Zou B#, Xie N#, 2021
From purines to purinergic signalling: molecular functions and human diseases, Huang Z*, Xie N*, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu SG, Huang C, Tang Y, 2021
Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment, Wu P*, Gao W*, Su M, Nice EC, Zhang W, Lin J#, Xie N#, 2021
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential, Xie N*, Zhang L*, Gao W*, Huang C, Huber PE, Zhou X, Li C#, Shen G#, Zou B#, 2020
Managing therapeutic resistance in breast cancer: from the lncRNAs perspective, Peng L, Jiang J, Tang B, Nice EC, Zhang YY#, Xie N#, 2020
Overcoming cancer therapeutic bottleneck by drug repurposing, Zhang Z*, Zhou L*, Xie N*, Nice EC, Zhang T, Cui Y, Huang C, 2020
PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation, Xie N*, Yuan K*, Zhou L, Wang K, Chen HN, Lei Y, Lan J, Pu Q, Gao W, Zhang L, Shen G, Li Q, Xiao H, Tang H, Xiang R, He M, Feng P, Nice EC, Wei Y, Zhang H, Yang J, Huang C, 2016

Virus-Induced Tumorigenesis Interaction Networks Oxidative Stress Metabolic Regulation Cell Autophagy Intervention Strategies Cancer Therapy Immune Response Nanoparticles Drug Delivery

Jingyu Li - Sichuan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us